Pharmafile Logo
Pharmafocus logo
Advanced Search
NICE building

Mepact wins NICE backing

October 26, 2011
Research and Development, Sales and Marketing Mepact, NICE

NICE has recommended Takeda’s bone cancer drug Mepact after the firm offered a discount for the treatment. The watchdog’s final …

News

Reforms raise conflicts of interest, say GPs

October 25, 2011
Sales and Marketing BMA, NHS, NHS reforms

Two-thirds of doctors believe that the government’s health reforms will create conflicts of interests in their jobs and undermine their …

News
Novartis HQ

Novartis to cut 2,000 jobs

October 25, 2011
Manufacturing and Production, Research and Development

Novartis will cut around 2,000 jobs is the US and Switzerland as part of additional cost saving measures. The positions …

News

David Meeker appointed as chief executive of Genzyme

October 25, 2011
Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …

Appointment

Pharma manufacturing news in brief

October 25, 2011
Manufacturing and Production pharma manufacturing news

Patheon wins a new contract from Boehringer Ingelheim, Ferring buys a UK plant, plus updates from InvaGen, CrossJect and contract …

News

New venture a ‘game-changer’ for pharma

October 25, 2011
Research and Development Sir Christopher Evans, drug development

Sir Christopher Evans is looking to create a new venture that aims to improve on the drug development productivity of …

News
GSK HQ

GSK warned by FDA about Worthing plant

October 25, 2011
Manufacturing and Production

The US FDA has issued a warning letter to GlaxoSmithKline, noting that its manufacturing plant in Worthing, UK, failed to …

News
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011
Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …

News

Flamel secures production contract for GSK heart failure drug

October 25, 2011
Manufacturing and Production Coreg CR, Flamel, GSK, manufacturing

France’s Flamel Technologies has won a long-term contract from GlaxoSmithKline focusing on the production of the drugmaker’s Coreg CR heart …

News

Risk Based Inspections for good pharmacovigilance practice

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …

News
Press release
Twitter feed

#fakedrugs: Scammers using Twitter to peddle fake medicines

October 24, 2011
Medical Communications Digital Pharma blog, Twitter

 Scammers are exploiting Twitter to entice people into buying fake medicines, according to a new report. The report, published by …

News
Lab image

Does drug development deliver on its promises?

October 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, R&D

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …

Feature

TranslateMedia listed in Deloitte UK Technology Fast 50 for 2011

October 24, 2011

The Deloitte UK Technology Fast 50 was founded in 1998, and remains one of Britain’s foremost technology programs. The program …

News
Press release
Merck image

Merck to invest $1billion in Singapore R&D and manufacturing

October 24, 2011
Manufacturing and Production, Research and Development

Singapore has reinforced its position as a major pharmaceutical hub for the Asia-Pacific region with the news that Merck is …

News

Bristol-Myers Squibb makes three senior management changes

October 24, 2011
Medical Communications, Research and Development, Sales and Marketing BMS

BMS has made three changes to its senior management with Giovanni Caforio promoted to president of US pharmaceuticals and Charles …

Appointment
Depakote

Abbott to pay $1.3 billion for Depakote lawsuits

October 24, 2011
Research and Development, Sales and Marketing Abbott, Depakote

 

News

Merck Serono returns Parkinson’s drug rights to Newron

October 24, 2011
Research and Development, Sales and Marketing Merck Serono, Newron

Merck Serono has returned the rights to the Parkinson’s disease drug safinamide back to Newron. The decision comes after the …

News

Number of CCGs continues to shrink

October 23, 2011
Sales and Marketing CCG, CCGs, NHS reform, clinical commissioning, primary care

The number of regional groups preparing to take over control of the NHS in England is rapidly shrinking, as the …

News

Amgen poaches Tony Hooper from Bristol-Myers Squibb

October 21, 2011
Medical Communications Amgen, BMS

Amgen has appointed Tony Hooper as the new executive vice president of global commercial operations. Hooper, 56, joins Amgen after …

Appointment

Abbott spin-off could attract mega merger

October 21, 2011
Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026